EUVIMEDEUVIMED entdecken
Leserbrief

Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients

Rachel M Kirven, Kristopher Fisher, Benjamin H Kaffenberger, Catherine G Chung, Abraham M Korman

Archives of Dermatological Research · 2024

DOI: 10.1007/s00403-024-03083-0 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Rachel M Kirven und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The Ohio State University, 540 Officenter Place, Suite 240, Columbus, OH, USA. Hauptthemen laut MEDLINE: Exanthema, Anti-Bacterial Agents, Drug Eruptions, Phenotype. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 3 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) is classically considered a low-risk, self-limiting eruption lacking systemic manifestations and sparing facial and mucosal areas. We present 7 inpatients meeting diagnostic criteria for SDRIFE with concomitant systemic manifestations ± high-risk facial involvement acutely after antibiotic exposure (mean latency 6.71 days). These cases deviate from classic, self-limited SDRIFE and represent a unique phenotype of SDRIFE, characterized by coexisting extracutaneous manifestations. Onset of systemic stigmata coincided with or preceded cutaneous involvement in 4 and 3 patients, respectively. All patients developed peripheral eosinophilia and 6 patients had ≥ 2 extracutaneous systems involved. Facial involvement, a high-risk feature associated with severe cutaneous adverse reactions but atypical in classic SDRIFE, occurred in 4 cases. Patients had favorable clinical outcomes following drug cessation and treatment with 4-6 week corticosteroid tapers. We suggest that baseline labs be considered in hospitalized patients with antibiotic-induced SDRIFE. These patients may also necessitate systemic therapy given extracutaneous involvement, deviating from standard SDRIFE treatment with drug cessation alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExanthemaAnti-Bacterial AgentsDrug EruptionsPhenotypeHumansMaleFemaleMiddle AgedAgedAdultHospitalizationEosinophilia

Stichwörter der Autor:innen

AntibioticsDrug overlap syndromesInpatient dermatologySevere cutaneous adverse reactionSymmetrical drug-related intertriginous and flexural exanthemcutaneous drug reactions

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Dermatology, The Ohio State University, 540 Officenter Place, Suite 240, Columbus, OH, USA.
  • Department of Dermatology, The Ohio State University, 540 Officenter Place, Suite 240, Columbus, OH, USA. Abraham.Korman@gmail.com.

Zitieren

APA

Kirven, R. M., Fisher, K., Kaffenberger, B. H., Chung, C. G., & Korman, A. M. (2024). Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03083-0

Vancouver

Kirven RM, Fisher K, Kaffenberger BH, Chung CG, Korman AM. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-03083-0

BibTeX
@article{Kirven2024,
  author = {Kirven, Rachel M and Fisher, Kristopher and Kaffenberger, Benjamin H and Chung, Catherine G and Korman, Abraham M},
  title = {Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients},
  journal = {Archives of Dermatological Research},
  year = {2024},
  doi = {10.1007/s00403-024-03083-0}
}
Kostenlos starten →